Rejuvenated ageing mesenchymal stem cells by stepwise preconditioning ameliorates surgery-induced osteoarthritis in rabbits. Issue 1 (1st January 2021)

• Record Type: Journal Article
• Authors: Zong, Zhixian; Zhang, Xiaoting; Yang, Zhengmeng; Yuan, Weihao; Huang, Jianping; Lin, Weiping; Chen, Ting; Yu, Jiahao; Chen, Jiming; Cui, Liao; Li, Gang; Wei, Bo; Lin, Sien
• Is Part Of: Bone & joint research. Volume 10:Issue 1(2021)
• Page Start: 10
• Page End: 21
• Publication Date: 2021-01-01
• Subjects: Osteoarthritis -- Mesenchymal stem cell -- Chondrogenic differentiation -- Ageing cell; Musculoskeletal system -- Periodicals; 573.705
• DOI: 10.1302/2046-3758.101.BJR-2020-0249.R1
• Languages: English
• ISSNs: 2046-3758

Abstract

Abstract : Aims: Ageing-related incompetence becomes a major hurdle for the clinical translation of adult stem cells in the treatment of osteoarthritis (OA). This study aims to investigate the effect of stepwise preconditioning on cellular behaviours in human mesenchymal stem cells (hMSCs) from ageing patients, and to verify their therapeutic effect in an OA animal model. Methods: Mesenchymal stem cells (MSCs) were isolated from ageing patients and preconditioned with chondrogenic differentiation medium, followed by normal growth medium. Cellular assays including Bromodeoxyuridine / 5-bromo-2'-deoxyuridine (BrdU), quantitative polymerase chain reaction (q-PCR), β-Gal, Rosette forming, and histological staining were compared in the manipulated human mesenchymal stem cells (hM-MSCs) and their controls. The anterior cruciate ligament transection (ACLT) rabbit models were locally injected with two millions, four millions, or eight millions of hM-MSCs or phosphate-buffered saline (PBS). Osteoarthritis Research Society International (OARSI) scoring was performed to measure the pathological changes in the affected joints after staining. Micro-CT analysis was conducted to determine the microstructural changes in subchondral bone. Results: Stepwise preconditioning approach significantly enhanced the proliferation and chondrogenic potential of ageing hMSCs at early passage. Interestingly, remarkably lower immunogenicity and senescence was also found in hM-MSCs. Data from animal studies showed cartilage damage was retarded and subchondral bone remodelling was prevented by the treatment of preconditioned MSCs. The therapeutic effect depended on the number of cells applied to animals, with the best effect observed when treated with eight millions of hM-MSCs. Conclusion: This study demonstrated a reliable and feasible stepwise preconditioning strategy to improve the safety and efficacy of ageing MSCs for the prevention of OA development. Cite this article: Bone Joint Res 2021;10(1):10–21.